アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1), selenious acid (unii: f6a27p4q4r) (selenious acid - unii:f6a27p4q4r) - zinc cation 22 mg in 1 ml - this formulation is indicated for use as a supplement to intravenous solutions given for tpn. administration of the solution in tpn solutions helps to maintain plasma levels of zinc, copper, manganese, selenium and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. multitrace® - 5 concentrate should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1) - zinc cation 4.39 mg in 1 ml - this formulation is indicated for use as a supplement to intravenous solutions given for tpn for children up to 11 years of age. administration of the solution in tpn solutions helps to maintain plasma levels of zinc, copper, manganese, and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. multitrace ® - 4 pediatric should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1) - zinc cation 6.6 mg in 1 ml - multitrace ® - 4 neonatal is indicated for use as a supplement to intravenous solutions given for tpn. administration of multitrace ® - 4 neonatal in tpn solutions helps to maintain plasma levels of zinc, copper, manganese, and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. multitrace ® - 4 neonatal should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1) - zinc cation 2.2 mg in 1 ml - this formulation is indicated for use as a supplement to intravenous solutions given for tpn for children up to 11 years of age. administration of the solution in tpn solutions helps to maintain plasma levels of zinc, copper, manganese, and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. trace elements injection 4, usp pediatric should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1) - zinc cation 4.39 mg in 1 ml - this formulation is indicated for use as a supplement to intravenous solutions given for tpn. administration of the solution in tpn solutions helps to maintain plasma levels of zinc, copper, manganese, and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. multitrace ® - 4 should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis. warnings: copper and manganese are eliminated via the bile. in patients with severe liver dysfunction and/or biliary tract obstruction, decreasing or omitting copper and manganese supplements entirely may be necessary. this product contains aluminum that may be toxic. aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum. research indicate

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1), selenious acid (unii: f6a27p4q4r) (selenious acid - unii:f6a27p4q4r) - zinc cation 4.39 mg in 1 ml - this formulation is indicated for use as a supplement to intravenous solutions given for tpn. administration of the solution in tpn solutions helps to maintain plasma levels of zinc, copper, manganese, selenium and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. multitrace ® - 5 should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate (unii: 89ds0h96tb) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), selenious acid (unii: f6a27p4q4r) (selenious acid - unii:f6a27p4q4r) - tralement™ is indicated in adult and pediatric patients weighing at least 10 kg as a source of zinc, copper, manganese, and selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. tralement is contraindicated in patients with hypersensitivity to zinc or copper [see warnings and precautions (5.7 )]. risk summary administration of the recommended dose of tralement in parenteral nutrition is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. deficiency of trace elements may result in adverse pregnancy and fetal outcomes (see clinical considerations). animal reproduction studies have not been conducted with tralement or with the individual trace elements. the estimated background risk of major birth defects and miscarriage for the indicated populations is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate (unii: 89ds0h96tb) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), selenious acid (unii: f6a27p4q4r) (selenious acid - unii:f6a27p4q4r) - multrys is indicated in neonatal and pediatric patients weighing less than 10 kg as a source of zinc, copper, manganese, and selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. multrys is contraindicated in patients with hypersensitivity to zinc or copper [see warnings and precautions  (5.7 )]. multrys is approved for use in neonatal and pediatric patients weighing less than 10 kg as a source of zinc, copper, manganese, and selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.  safety and dosing recommendations in pediatric patients less than 10 kg are based on published literature describing controlled studies of products containing zinc, copper, manganese, and selenium [see dosage and administration (2.5)] . copper is primarily excreted in the bile.  excretion is decreased in patients with cholestasis and/or cirrhosis.  manganese is presumed to be excreted in bile [see clinical pharm

カナダ - 英語 - Health Canada

sandoz canada incorporated - zinc (zinc sulfate); copper (cupric sulfate); manganese (manganese sulfate); chromium (chromic chloride); selenium (selenious acid); iodine (sodium iodide) - liquid - 5mg; 1mg; 0.5mg; 10mcg; 60mcg; 75mcg - zinc (zinc sulfate) 5mg; copper (cupric sulfate) 1mg; manganese (manganese sulfate) 0.5mg; chromium (chromic chloride) 10mcg; selenium (selenious acid) 60mcg; iodine (sodium iodide) 75mcg - replacement preparations

カナダ - 英語 - Health Canada

sandoz canada incorporated - chromium (chromic chloride); zinc (zinc sulfate); copper (cupric sulfate); manganese (manganese sulfate) - liquid - 4mcg; 1mg; .4mg; .1mg - chromium (chromic chloride) 4mcg; zinc (zinc sulfate) 1mg; copper (cupric sulfate) .4mg; manganese (manganese sulfate) .1mg - replacement preparations